The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...
Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...
Morning Overview on MSN
Crispr reveals a new way to defeat resistant lung cancer
Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...
Expanded lung cancer screening and smoking cessation programs could prevent tens of thousands of deaths, but systemic barriers and outdated criteria leave high-risk communities behind.
Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.
WAUSAU, Wis. (WSAW) - In the past, being diagnosed with small-cell lung cancer seemed to be a death sentence. This type of cancer is known as one of the most aggressive and deadliest forms of cancer.
The research highlights the role of immune checkpoint inhibitors, drugs that enhance the body's ability to fight tumors.
Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.
Yale researchers recently discovered new genes that could be used to test potential treatment options for a rare form of aggressive lung cancer. Each year, about 6,000 Americans — roughly 3 percent of ...
A team of scientists have developed a simple method for automated manufacturing of lung organoids which could revolutionize ...
If everyone eligible had a lung cancer screening, 62,000 lives would be saved over five years, a new study shows.
Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer cells, even after the cancer has spread to other organs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results